[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid

C52H60BClF4N10O6 — CID 157467001

IUPAC[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid
SMILESC[C@H]1CN(c2nnc(-c3ccc(CO)cc3)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.C[C@H]1CN(c2nnc(Cl)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.OCc1ccc(B(O)O)cc1
InChIInChI=1S/C26H29F2N5O2.C19H22ClF2N5O.C7H9BO3/c1-17-15-32(12-13-33(17)25(35)20-6-9-26(27,28)10-7-20)24-22-14-29-11-8-21(22)23(30-31-24)19-4-2-18(16-34)3-5-19;1-12-11-26(17-15-10-23-7-4-14(15)16(20)24-25-17)8-9-27(12)18(28)13-2-5-19(21,22)6-3-13;9-5-6-1-3-7(4-2-6)8(10)11/h2-5,8,11,14,17,20,34H,6-7,9-10,12-13,15-16H2,1H3;4,7,10,12-13H,2-3,5-6,8-9,11H2,1H3;1-4,9-11H,5H2/t17-;12-;/m00./s1
InChIKeyBUPDTXGOPPGQKG-RRYGSMOZSA-N
MW1043.37 g/mol
LogP6.45
Rot. Bonds8

About [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid

[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid (PubChem CID 157467001) has the molecular formula C52H60BClF4N10O6 and a molecular weight of 1043.37 g/mol. Its IUPAC name is [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid.

Molecular Properties

Compound Name[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid
PubChem CID157467001
Molecular FormulaC52H60BClF4N10O6
Molecular Weight1043.37 g/mol
Exact Mass1042.44
IUPAC Name[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid
SMILESC[C@H]1CN(c2nnc(-c3ccc(CO)cc3)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.C[C@H]1CN(c2nnc(Cl)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.OCc1ccc(B(O)O)cc1
InChIInChI=1S/C26H29F2N5O2.C19H22ClF2N5O.C7H9BO3/c1-17-15-32(12-13-33(17)25(35)20-6-9-26(27,28)10-7-20)24-22-14-29-11-8-21(22)23(30-31-24)19-4-2-18(16-34)3-5-19;1-12-11-26(17-15-10-23-7-4-14(15)16(20)24-25-17)8-9-27(12)18(28)13-2-5-19(21,22)6-3-13;9-5-6-1-3-7(4-2-6)8(10)11/h2-5,8,11,14,17,20,34H,6-7,9-10,12-13,15-16H2,1H3;4,7,10,12-13H,2-3,5-6,8-9,11H2,1H3;1-4,9-11H,5H2/t17-;12-;/m00./s1
InChIKeyBUPDTXGOPPGQKG-RRYGSMOZSA-N
XLogP6.45
TPSA205.36 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001043.37
LogP ≤ 56.45
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid?
The IUPAC name of [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid (CID 157467001) is [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid.
What is the SMILES notation for [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid?
The canonical SMILES for [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid is C[C@H]1CN(c2nnc(-c3ccc(CO)cc3)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.C[C@H]1CN(c2nnc(Cl)c3ccncc23)CCN1C(=O)C1CCC(F)(F)CC1.OCc1ccc(B(O)O)cc1.
What is the InChIKey of [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid?
The InChIKey is BUPDTXGOPPGQKG-RRYGSMOZSA-N. The full InChI is InChI=1S/C26H29F2N5O2.C19H22ClF2N5O.C7H9BO3/c1-17-15-32(12-13-33(17)25(35)20-6-9-26(27,28)10-7-20)24-22-14-29-11-8-21(22)23(30-31-24)19-4-2-18(16-34)3-5-19;1-12-11-26(17-15-10-23-7-4-14(15)16(20)24-25-17)8-9-27(12)18(28)13-2-5-19(21,22)6-3-13;9-5-6-1-3-7(4-2-6)8(10)11/h2-5,8,11,14,17,20,34H,6-7,9-10,12-13,15-16H2,1H3;4,7,10,12-13H,2-3,5-6,8-9,11H2,1H3;1-4,9-11H,5H2/t17-;12-;/m00./s1.
What are the key properties of [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid?
[(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid has a molecular weight of 1043.37 g/mol, XLogP of 6.45, 8 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-2-methylpiperazin-1-yl]-(4,4-difluorocyclohexyl)methanone;(4,4-difluorocyclohexyl)-[(2S)-4-[1-[4-(hydroxymethyl)phenyl]pyrido[3,4-d]pyridazin-4-yl]-2-methylpiperazin-1-yl]methanone;[4-(hydroxymethyl)phenyl]boronic acid is sourced from PubChem (CID 157467001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).